President Trump’s executive order on Monday turned a harsh spotlight on pharmaceutical companies’ long-standing practice of charging Americans far more for prescription drugs than they charge consumers in other countries.
The order’s language remains vague — it mentions only future “price targets” and possible enforcement mechanisms — but the message is unmistakable: The U.S. government will no longer tolerate paying inflated prices for drugs when European governments negotiate far lower ones.
Americans crushed by high drug costs also vote — and they can elect a president and Congress willing to rewrite the rules.
Trump’s order addresses just one part of a larger, deeply rooted problem: the runaway cost of prescription drugs in the United States. A major contributor to that cost is the pricing of patent-protected
Trending: President Trump Reveals Touching Reason He Was In Such A Hurry To Leave UAE
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!